BlogHeader.png

Quality and Regulatory Affairs Notification Letter

By now you should have been notified about our organizations next important step in the transition of joining AAIPharma Services Corp., a leading provider of drug product, development services and analytical testing, with Cambridge Major Laboratories, Inc., a world-class API drug developer and manufacturer. Effective March 16, 2016, our company will officially operate under the name Alcami [al-kuh-mee]. 

The previous name of our business units have been changed with state and local governments, in the D&B database, and with the FDA.  All of our sites within our organization are doing business as (dba) Alcami Corporation.  Following is a table that outlines how each site name / address / FEI / DUNS is identified with the FDA.

Alcami Announces Enhanced Laboratory Services in Wilmington, NC Headquarters

Wilmington, NC – June 20, 2016 – Alcami, a leading provider of custom development and manufacturing services for the pharmaceutical and biotechnology industries, today announces it has taken major steps in upgrading its laboratory service capabilities to meet market and client demands. Approximately 5,000 square feet of the current Technology Center located in Wilmington, NC will be converted to newly reconstructed laboratory space.

Topics: Company News